Professional Documents
Culture Documents
Beta- Blockers
Bisoprolol OD Take after Suhoor
. Metoprolol OD Take after Suhoor
. Atenolol OD Take after Iftar and Suhoor
Propranolol BID/TID Take after Iftar and Suhoor
Labetolol BID/TID/QID Calculate the TDD and give BID after
Methyldopa BID/TID/QID Iftar(2/3) and Suhoor(1/3)
Clonidine BID/TID
Carvedilol BID Take with fatty meal (dinner) to avoid abrupt
fall in BP
CCBs
Dihydropyridine e.g.
amlodipine or nifedipine OD/ BID Take after Iftar or Suhoor
Non–dihydropyridine e.g. Take after Iftar and Suhoor
verapamil and diltiazem OD/BID/TID
Thiazide diuretic
Hydrochlorothiazide OD - might cause dehydration Take after Ishaa prayer
Metalazone Avoid taking suhoor time
Amiloride 5mg/ OD
Spironolactone OD – HF-depends on patient Take after iftar prayer
clinical condition Liver cirrhosis – fasting not advisable
BID /TID – Liver cirrhosis
Antiplatelet e.g. OD - Aspirin and clopidogrel OD: take after the full Iftar meal (preferably
aspirin, Increased resistance in diabetic 8pm):
clopidogrel and patients during fasting Combination : take after the full Iftar meal
dyrypidimole (preferably 8pm):
Combination of aspirin and
1-To achieve the full synergistic effect next
clopidogrel
day morning 10 am where platelet
aggregation is at highest rate induced by
both drugs
2-After meal to avoid the stomach irritation.
Strict adherence is recommend
Flecainide BID Take after Iftar and Suhoor Interval between doses
should not be less than 8 hours
Dabigatran BID - Might increase GI Take after full Iftar and Suhoor Interval should
disturbance be ≥ 8 hours
Apixaban BID Take after full Iftar and Suhoor Interval should
be ≥ 8 hours
Benzodiazepines
Diazepam OD /BID/ PRN doses Take after Iftar (preferred after Ishaa pray)
Lorazepam OD Clinical judgment : Advice not to fast if
Bromazepam OD clinically unstable
Sodium Valproate Regular formulation – Take after Iftar and Suhoor
BID/TID Chrono – OD or BID
Food may decrease absorption take 1-2 hour after
Iftar or 1 hour before suhoor
Oxcarbazepine BID Take after Iftar and Suhoor
Lamotrigine (IR) Initiation OD or BID Clinical judgment. Take after Iftar and/or suhoor
Same time daily
Lamotrigine (MR) OD Take after Iftar and Suhoor (same time daily)
Gliclazide IR: BID Take after iftar and 2 hours before suhoor to
avoid daytime hypoglycaemia ( if good
glycaemic control, advice to reduce the suhoor
dose by 50%)
Glimepiride OD 2mg – 4mg OD: To be taken after iftar
Max. 8mg 6mg OD : Reduce to 4mg and give after iftar
Above 6mg give into 8mg OD: Give 4mg BID, 4mg after iftar and
divided doses BID reduce the 2nd dose to 2mg and give 2 hours
before suhoor.
Long- or intermediate
acting basal insulin OD Take at Iftar.
e.g. Glargine /Degludec Reduce dose by 15–30% if good glycaemic
(Tresiba)l Detemir control
Rapid- or short-acting
prandial/bolus insulin -Take normal dose at Iftar Omit lunch time
e.g. Lispro TID dose
Aspart -Reduce Suhoor dose by 25–50% based on
Actrapid patients glycaemic status.
If good glycaemic control reduce the dose by
50%
Patients with frequent hypo and hyperglycemia are not advised to fast.
Patients with major diabetic complications are not advised to fast.
-Option 1:
Give Augmentin 1g formula every 12
URTIs Amoxicillin 250mg – TID hourly if available
5oomg Option 2:
TID Change to Clarithromycin BID x 5 days
Augmentin 375mg - 625mg or
Azithromycin OD x 3 days
Option 1:
Soft tissue Change to cefadroxil 500-100mg BID x
infections QID 5 days
Cloxacillin 250mg -5oomg -Do not fast till completion of course
Amoxicillin 250mg – TID Option 1:
LRTIs 5oomg Give Augmentin 1g formula every 12
TID hourly if available
Augmentin 375mg - 625mg Option 2:
Change to Clarithromycin BID x 5 days
or
Azithromycin 250 -500mg OD x 3 to 5
days or
Levofloxacin OD or BID x 5 days
Option 1:
Amoxicillin 250mg – TID Give Augmentin 1g formula every 12
5oomg hourly if available
TID Option 2:
Community- Augmentin 375mg - 625mg Change to Clarithromycin BID x 5 days
Acquired or
Pneumonia Azithromycin 250 -500mg OD x 3 to 5
days or
Levofloxacin OD or BID x 5 days
BID
HIV -Emtricitabine -300mg BD To be taken after iftar and after suhoor (fatty
meal)
Nucleoside
reverse -Lamivudine -200mg OD - To be taken before or after suhoor
transcriptase
inhibitors
(NRTIs) -Stavudine -50/100/150mg - To be taken before or after suhoor
- Lamivadine + Zidovidine
+ efavirenz - -to be taken with or without food, efavirenz
150/300/600mg to be taken 2 hours before suhoor
- bictegravir, emtricitabine, OD
tenofovir alafenamide
-50/200/25mg -to be taken with or without food(fatty meal)
- Favipiravir -200mg - to be taken after iftar or suhoor
OD/BD
Antidepressants BID
Paroxetine 20mg OD
Fluoxerine 20mg OD
Amitryptiline 25mg
Domperidone TID
Metoclopramide TID -To be taken BID
Mebeverine TID -2 hours after Iftar and 30 min before Suhoor
Meselazamine 500mg BD
-To be taken 2 hours after iftar and 1 hour before
suhoor
(Salofak) 0.5g TID - (2 tab) 2 hours after iftar and (2tab)1 hour
before suhoor
1g TID
-(3 tab) 2 hours after suhoor and ( 3 tab) 1 hour
before suhoor
(Pentasa) 4g BID -(2tab) after iftar and (2tab) after suhoor
2g OD -(2tab) after iftar
Sirolimus 1mg OD
To be taken after suhoor
Ciclosporin 25mg – 50mg – 100mg
BID To be taken with iftar and with suhoor
In General:
Patient Education and Awareness is of paramount with regards appropriate use of medication during
this holy month of Ramadan.
Try to switch to longer –acting (Extended-release form that requires to be given once or twice daily)
Patients with chronic unstable medical conditions should be advised not to fast.
Patients may be reminded about conditions that exempted from fasting according to Islamic scholars
rules if possible.
Choice of fasting is entirely left on patient to decide, we as healthcare professional are involved in
advising, education and informing the patient about potential harm of fasting (high risk patient willing
to fast) and the precautionary measures to be taken in case of any complication that might occur during
or after the period of fasting.
Special attention must give to elderly patients and patients with chronic co-mordities (multiple medical
conditions) who are on polypharmacy that may further pose their health at risk.
For further queries and information please call Drug Information (DIC) and Training Centre